Healthcare services

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

Capitol Health’s first half results exceeded brokers’ expectations with higher margins thanks largely to stringent cost control

Mar 13 2024

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on Ramsay Health Care

Oct 26 2023


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
ACL AUSTRALIAN CLINICAL LABS LIMITED $2.54 $3.72 $2.26 16.5

$3.133

ALC ALCIDION GROUP LIMITED $0.04 $0.13 $0.04

$0.05

BMT BEAMTREE HOLDINGS LIMITED $0.18 $0.33 $0.17

$0.70

CAJ CAPITOL HEALTH LIMITED $0.24 $0.30 $0.19 28.2

$0.315

DOC DOCTOR CARE ANYWHERE GROUP PLC $0.07 $0.09 $0.04

$0.12

EBO EBOS GROUP LIMITED $31.98 $xx.xx $xx.xx xx.x xx.xx
HLS HEALIUS LIMITED $1.23 $xx.xx $xx.xx xx.x xx.xx
M7T MACH7 TECHNOLOGIES LIMITED $0.72 $xx.xx $xx.xx xx.x xx.xx
MDR MEDADVISOR LIMITED $0.26 $xx.xx $xx.xx xx.x xx.xx
MPL MEDIBANK PRIVATE LIMITED $3.70 $xx.xx $xx.xx xx.x xx.xx
MVF MONASH IVF GROUP LIMITED $1.42 $xx.xx $xx.xx xx.x xx.xx
NHF NIB HOLDINGS LIMITED $7.70 $xx.xx $xx.xx xx.x xx.xx
PSQ PACIFIC SMILES GROUP LIMITED $1.65 $xx.xx $xx.xx xx.x xx.xx
RHC RAMSAY HEALTH CARE LIMITED $52.15 $xx.xx $xx.xx xx.x xx.xx
SHL SONIC HEALTHCARE LIMITED $27.55 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
Timing Seems Right For Alcidion Group

Jun 21 2023

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand


No Enthusiasm To Combine ACL & Healius

Mar 21 2023

A takeover bid for Healius by Australian Clinical Labs has been greeted with very little enthusiasm, if any


Dr Boreham’s Crucible: Alcidion

Dec 13 2022

Tim Boreham highlights opportunities for SaaS company Alcidion, which tracks patients through the medical system


No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022

Following first quarter results, some brokers anticipate rising margins for Ramsay Health Care though overseas operations are harder to forecast


Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player


Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022

FY22 results for Australian Clinical Labs missed expectations and brokers await an uptick in non-covid testing


Healius Offers Digital Carrot, Base Remains Soft

May 25 2022

Recovery in the core business remains important in the near-term for Healius, as benefits from covid testing look likely to soften in the remainder of the year, but longer-term digitisation remains a focus for the company


Ramsay Stakes Future on Mental Health

Dec 20 2021

Its latest acquisition has increased Ramsay Health Care’s exposure to the high growth mental health care segment, but potential opportunity has largely failed to impress analysts


Ramsay Health Care: Finally A Break-Out

Nov 09 2021

Michael Gable of Fairmont Equities notes Ramsay Health Care had been range-bound for a year thus a break-out is significant


Funding Overhang Weighs On Ramsay’s Rebound

Jun 10 2021

With earnings momentum coming out of covid, Ramsay Health Care looks set to rebound from the pandemic downturn in surgeries, but the Spire acquisition raises questions over its balance sheet and funding options